Libervant FDA Approval Status
Last updated by Judith Stewart, BPharm on Sep 1, 2022.
FDA Approved: No (Tentative Approval)
Brand name: Libervant
Generic name: diazepam
Dosage form: Buccal Film
Company: Aquestive Therapeutics, Inc.
Treatment for: Seizure Clusters
Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.
Development timeline for Libervant
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.